At what enterprise value was INLOG acquired in 2025?

During the acquisition of INLOG by GENII SOFTWARE GROUP in 2025, the company was valued at an estimated revenue multiple of 5x - 12x. The transaction's Enterprise Value is estimated to be in the range of 50M - 150M EUR. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the TMT (Tech, Media, Telecom) industry currently tracks an average EBITDA multiple of 14.3x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of INLOG when it was acquired by GENII SOFTWARE GROUP?

The estimated EV/EBITDA multiple for INLOG is in the range of 15x - 25x. For comparison, the TMT (Tech, Media, Telecom) sector currently shows an average EBITDA multiple of 14.3x. Join our community for free to access full valuation data and industry trends.

When was INLOG acquired by GENII SOFTWARE GROUP?

INLOG was acquired by GENII SOFTWARE GROUP in 2025.

What was the revenue of INLOG at the time of the deal?

The revenue of INLOG at the time of the deal is estimated to be in the range of 5M - 25M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of INLOG during the acquisition?

INLOG's EBITDA is estimated to be in the range of 5M - 25M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the INLOG acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the INLOG deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.lincolninternational.com/transactions/abenex-has-sold-inlog-to-genii-software-group-a-portfolio-company-of-bregal/

← DATABASE

Home Database TMT (Tech, Media, Telecom)INLOG

09/2025

INLOG acquired by GENII SOFTWARE GROUP

FRANCE Software / Industry-Specific Software / Healthcare EV 50M - 150M EUR

Context

Private equity firm Abenex, alongside the management team, has successfully completed the divestiture of healthcare software publisher Inlog to Munich-based GENII Software Group. Orchestrated by investment bank Lincoln International, the transaction marks the exit of Abenex following a successful transformation period. The acquirer, GENII Software Group, is majority-backed by private equity sponsor Bregal Unternehmerkapital, with additional support from Elvaston. For the acquirer GENII Software Group, the buyout significantly strengthens its Laboratories division and consolidates its position as a leading European provider of specialized enterprise software. During Abenex's ownership tenure, Inlog doubled its revenues, completed three strategic acquisitions, and expanded its footprint into Germany and the Benelux region. Partnering with GENII will provide Inlog with the necessary scale and resources to accelerate international revenue growth and drive product innovation, particularly focusing on AI and cloud-based technologies.

Abenex in 2020 had previously taken control of the company during an LBO.

INLOG, which reported an EBITDA margin of LOGIN in 2024, is valued in this transaction at an EV/EBITDA multiple of LOGIN, representing a LOGIN to the average currently observed in the TMT (Tech, Media, Telecom) sector (14.3x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in TMT (Tech, Media, Telecom) market trends

Target

Inlog is a software editor for the healthcare sector, specializing in blood product traceability and laboratory management. Founded after its spin-off from the American Haemonetics Corporation, Inlog has structured its teams and now has 80 employees worldwide. The company opened a subsidiary in Germany in 2022 and generates nearly 20% of its revenue internationally. Inlog offers innovative solutions for healthcare systems and has made several acquisitions, including the French companies Ubilab and Viskali, as well as the Belgian company Moonchase.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2024

2023

Other operations with INLOG

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
09/2020	ABENEX	INLOG	FRANCE	Software	Private equity firm Abenex, utilizing its dedicated Small Caps fund Abenex Croissance, has successfully completed the acquisition of healthcare software publisher Inlog from US-based industrial group Haemonetics. Executed on September 21, 2020, this corporate carve-out ends a 12-year integration within the American conglomerate, with Inlog's management team reinvesting alongside the new financial sponsor. The buyout is supported by a senior debt facility co-arranged by Banque Populaire Val de France and Caisse d’Epargne Rhône-Alpes. This transaction represents the fourth platform investment for the Abenex Croissance fund. For Abenex, the investment is designed to provide the necessary resources to institutionalize the internationally active software publisher and accelerate its operational growth. Leveraging this new financial backing, Inlog will expedite the development of new functional features for its CE-marked medical device software, which provides mission-critical blood product traceability and laboratory management solutions. Furthermore, the company aims to solidify its strategic partnerships with its base of over 250 French and European clients, which prominently includes university hospitals (C.H.U.) and the French Blood Establishment (EFS).

REFERENCES

Valuation range: EV 50M - 150M EUR

Revenue range: 5M - 25M EUR

EBITDA range: 5M - 25M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of INLOG by GENII SOFTWARE GROUP are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: inlog

Acquirer: genii software group